Former PHAS professor Carl Hansen featured in media for successful AbCellera IPO | UBC Physics & Astronomy
IPO Stock AbCellera Eyes Profitability As Covid-19 Antibody Sales Soar | Investor's Business Daily
Vancouver's AbCellera on hiring spree after smash IPO | Venture
BioCentury - AbCellera valuation tops $15B as 2020's IPO class nears completion
AbCellera officially closes initial public offering with $555.5 million gross proceeds | BetaKit
IPO: AbCellera Biologics
VC-backed AbCellera seeks up to C$500m from IPO: Reuters
/cloudfront-us-east-1.images.arcpublishing.com/tgam/SXPTX25NH5BV5HCRRZ2OZZOU3Y.jpg "With historic financing, AbCellera becomes champion of Canada's surging biotechnology sector - The Globe and Mail")
With historic financing, AbCellera becomes champion of Canada's surging biotechnology sector - The Globe and Mail
Thiel-backed therapy developer AbCellera looks to raise up to $391 million in IPO | Reuters
A Canadian biotech giant is born: AbCellera stock triples in debut, company now worth US$15-billion - The Globe and Mail
AbCellera - Products, Competitors, Financials, Employees, Headquarters Locations
IPO Launch: AbCellera Biologics Readies $357 Million IPO - IPOs On TheStreet - U.S. IPO Research & Opinion
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation | Fierce Biotech
AbCellera IPO: Shares debut at US$20 in blockbuster bid for B.C. biotech - Technology | Business in Vancouver
AbCellera Biologics to raise up to US $391M from NASDAQ IPO at up to US $4.52B valuation - Private Capital Journal
Wish & AbCellera Biologics Inc: Investors' Hawk-eyed On These 2 IPOs | Kalkine Media
Vancouver biotech company AbCellera's IPO nets $556M | Venture
Pre-IPO: Everything You Need To Know About AbCellera (Part I) (NASDAQ:ABCL) | Seeking Alpha
DoorDash, Airbnb Lead Big IPO Week—but Peter Thiel's AbCellera Could Be the Winner | Barron's
